195 related articles for article (PubMed ID: 6350033)
1. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
Boman G; Bäcker U; Larsson S; Melander B; Wåhlander L
Eur J Respir Dis; 1983 Aug; 64(6):405-15. PubMed ID: 6350033
[TBL] [Abstract][Full Text] [Related]
2. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.
Rasmussen JB; Glennow C
Eur Respir J; 1988 Apr; 1(4):351-5. PubMed ID: 3294038
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
[TBL] [Abstract][Full Text] [Related]
4. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
[TBL] [Abstract][Full Text] [Related]
5. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
Brocard H; Charpin J; Germouty J
Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral N-acetylcysteine on mucus clearance.
Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators.
Meister R; Wittig T; Beuscher N; de Mey C
Arzneimittelforschung; 1999 Apr; 49(4):351-8. PubMed ID: 10337455
[TBL] [Abstract][Full Text] [Related]
8. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study.
Eur J Respir Dis Suppl; 1980; 111():93-108. PubMed ID: 7011836
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
Aylward M; Maddock J; Dewland P
Eur J Respir Dis Suppl; 1980; 111():81-9. PubMed ID: 7011835
[No Abstract] [Full Text] [Related]
10. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
[TBL] [Abstract][Full Text] [Related]
12. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test.
Ghanei M; Shohrati M; Jafari M; Ghaderi S; Alaeddini F; Aslani J
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):428-32. PubMed ID: 18801028
[TBL] [Abstract][Full Text] [Related]
14. The effect of RU 41.740, an immune modulating compound, in the prevention of acute exacerbations in patients with chronic bronchitis.
Bonde J; Dahl R; Edelstein R; Kok-Jensen A; Lazer L; Punakivi L; Seppala A; Soes-Petersen U; Viskum K
Eur J Respir Dis; 1986 Oct; 69(4):235-41. PubMed ID: 3545882
[TBL] [Abstract][Full Text] [Related]
15. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
16. [Acetylcysteine].
Köhler D
Dtsch Med Wochenschr; 1996 Dec; 121(49):1550. PubMed ID: 8998925
[No Abstract] [Full Text] [Related]
17. [The mucolytic effects of acetylcysteine compared with bromhexine and a placebo in patients with chronic bronchitis].
Heinig JH; Pedersen B; Andersen I; Dalgaard CE; Rasmussen O; Weeke ER; Enk B
Ugeskr Laeger; 1985 Nov; 147(46):3694-7. PubMed ID: 3907080
[No Abstract] [Full Text] [Related]
18. [Double-blind study of Biostim in the prevention of superinfection in patients with chronic bronchopathy].
Anthoine D; Blaive B; Cabanieu G; Chretien J; Danrigal A; Ducreuzet C; Dusser D; Leophonte P; Migueres J; Muir JF
Rev Pneumol Clin; 1985; 41(3):213-7. PubMed ID: 3901218
[TBL] [Abstract][Full Text] [Related]
19. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.
Moretti M; Bottrighi P; Dallari R; Da Porto R; Dolcetti A; Grandi P; Garuti G; Guffanti E; Roversi P; De Gugliemo M; Potena A;
Drugs Exp Clin Res; 2004; 30(4):143-52. PubMed ID: 15553660
[TBL] [Abstract][Full Text] [Related]
20. [The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis].
Pirozyński M; Skucha W; Słomiński M; Chyczewska E; Malinowski J; Nowak D; Bartmińiski W; Pachocki R;
Pol Merkur Lekarski; 2005 Aug; 19(110):139-43. PubMed ID: 16245418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
